Iron and Copper Homeostasis in Cardiometabolic Disease: Therapeutic Potential of Chelators
Cardiometabolic diseases remain a leading global health burden, and growing evidence indicates that dysregulation of iron and copper homeostasis plays a central role in their pathogenesis. Two metal-dependent forms of regulated cell death—ferroptosis and cuproptosis—have recently emerged as key mech...
محفوظ في:
| المؤلفون الرئيسيون: | , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI AG
2026-03-01
|
| سلاسل: | Pharmaceuticals |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/1424-8247/19/3/441 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|